Price target
118.910.000.00%
The 23 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 27 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of ABT is 107.81 USD — it has decreased by −0.55% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Abbott Laboratories stocks are traded under the ticker ABT.
ABT stock has risen by 2.79% compared to the previous week, the month change is a 12.89% rise, over the last year Abbott Laboratories has showed a −17.80% decrease.
We've gathered analysts' opinions on Abbott Laboratories future price: according to them, ABT price has a max estimate of 135.00 USD and a min estimate of 103.00 USD. Watch ABT chart and read a more detailed Abbott Laboratories stock forecast: see what analysts think of Abbott Laboratories and suggest that you do with its stocks.
ABT stock is 1.85% volatile and has beta coefficient of −0.32. Track Abbott Laboratories stock price on the chart and check out the list of the most volatile stocks — is Abbott Laboratories there?
Today Abbott Laboratories has the market capitalization of 186.81 B, it has increased by 6.66% over the last week.
Yes, you can track Abbott Laboratories financials in yearly and quarterly reports right on TradingView.
Abbott Laboratories is going to release the next earnings report on Oct 21, 2026. Keep track of upcoming events with our Earnings Calendar.
ABT earnings for the last quarter are 1.31 USD per share, whereas the estimation was 1.28 USD resulting in a 2.56% surprise. The estimated earnings for the next quarter are 1.42 USD per share. See more details about Abbott Laboratories earnings.
Abbott Laboratories revenue for the last quarter amounts to 12.59 B USD, despite the estimated figure of 12.52 B USD. In the next quarter, revenue is expected to reach 12.99 B USD.
ABT net income for the last quarter is 928.00 M USD, while the quarter before that showed 1.08 B USD of net income which accounts for 0.00% change. Track more Abbott Laboratories financial stats to get the full picture.
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (TTM)% is 2.30%. Tracking Abbott Laboratories dividends might help you take more informed decisions.
Abbott Laboratories dividend yield was 1.92% in 2025, and payout ratio reached 64.54%. The year before the numbers were 1.98% and 29.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 7, 2026, the company has 115 K employees. See our rating of the largest employees — is Abbott Laboratories on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Abbott Laboratories EBITDA is 11.11 B USD, and current EBITDA margin is 25.67%. See more stats in Abbott Laboratories financial statements.
Like other stocks, ABT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abbott Laboratories stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Abbott Laboratories technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Abbott Laboratories stock shows the neutral signal. See more of Abbott Laboratories technicals for a more comprehensive analysis.